Gene ther­a­py start­up Jaguar set to join NC man­u­fac­tur­ing boom with $125M fa­cil­i­ty

Jaguar Gene Ther­a­py will join the North Car­oli­na biotech man­u­fac­tur­ing com­mu­ni­ty, with a $125 mil­lion in­vest­ment in a 174,000 square-foot fa­cil­i­ty that will sit down the road from the com­pa­ny’s Cary, NC lab­o­ra­to­ry.

The al­ready-ex­ist­ing site will be con­vert­ed to the com­pa­ny’s man­u­fac­tur­ing spec­i­fi­ca­tions and sup­port clin­i­cal and com­mer­cial man­u­fac­tur­ing of its ini­tial pro­grams, in­clud­ing galac­tosemia, a spe­cif­ic ge­net­ic cause of autism, and Type 1 di­a­betes. The first ther­a­pies are like­ly to en­ter the clin­ic in 2023.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER